In the first week of 2022, the IPO market was relatively flat. According to China stock market news choice, the average increase on the first day of IPO this week was 21.72%. Among them, 3D world rose 98.48% on the first day, and the single signature profit was nearly 15000 yuan.
Among the new shares next week, xidiwei, to be purchased on Tuesday, is one of China’s leading power management chip design enterprises. At present, in the field of consumer electronics such as mobile phones, the company’s DC / DC chips have been mass produced and shipped to Samsung, Xiaomi, voice transmission and other customers; In the field of automotive electronics, its DC / DC chip has entered Qualcomm’s global automotive platform reference design, and has been shipped to Audi, Hyundai, Kia and other auto companies.
It is worth mentioning that Yidong electronics, which will be subscribed on Wednesday, is in a leading position in China’s precision electronic parts and components industry. The company’s products are mainly used in the fields of consumer electronics, communications, new energy, automotive electronics, industry and medical treatment. The customer groups mainly include xinnengde, Sunwoda Electronic Co.Ltd(300207) , Byd Company Limited(002594) , Goertek Inc(002241) , Contemporary Amperex Technology Co.Limited(300750) , Luxshare Precision Industry Co.Ltd(002475) , Tianma microelectronics, Guangdong Goworld Co.Ltd(000823) and other well-known enterprises at home and abroad.
list of new shares next week
First, briefly review the IPO situation this week. From January 4 to January 7, a total of 4 new shares were listed in the A-share market, of which 3 rose and closed on the first day.
judging from the issue price, the only new share that fell on the first day of this week has an issue price of less than 30 yuan / share. It is an unprofitable enterprise on the science and innovation board.
In terms of the initial P / E ratio of , although the issuance price of Guoxin technology, another new share on the science and innovation board, corresponds to 418.95 times of the static PE, the increase on the first day of listing is still 11.29%.
looking at the change trend of performance, the three-dimensional world with the best performance on the first day of new shares is expected to have a net profit of 53.5 million yuan to 60 million yuan in 2021, an increase of 1.82% to 14.19% over the previous year.
According to the current arrangement, if there is no change, there will be four new shares available for subscription next week (January 10 to January 14), including one on the science and innovation board, two on the gem and one on the main board of Shanghai stock market.
Monday
Chengda pharmaceutical:
The company is mainly committed to providing key pharmaceutical intermediates and other products for multinational pharmaceutical enterprises and pharmaceutical R & D institutions, and engaged in the R & D, production and sales of L-carnitine series products.
Corresponding PE * adopts the caliber of “diluted P / E ratio before and after deducting non recurring profits and losses in 2020, whichever is lower”, the same below
Comparable PE * adopts “static non front” caliber
Chengda pharmaceutical expects the net profit in 2021 to be 103 million yuan to 105 million yuan, a decrease of 13.14% to 15.04% over the previous year. However, after deducting non recurring profits and losses, Chengda pharmaceutical’s performance is still positive growth, with a significant increase.
Chengda pharmaceutical prospectus
Tuesday
xidiwei:
The company is one of the leading semiconductor and integrated circuit design enterprises in China. Its main business is the R & D, design and sales of analog integrated circuits including power management chips and signal chain chips.
According to the prospectus, from January to September 2021, the company achieved an operating revenue of 353.6477 million yuan, an increase of 180.91% over the same period of the previous year, which is mainly due to the company’s continuous deepening of cooperation with brand customers, the continuous increase in the procurement scale of major customers such as anfuli, Qualcomm, Xiaomi, Chuanyin and oppo in Taiwan, and the company’s new brand customers such as Samsung and vivo, driving the rapid growth of revenue.
Xidiwei expects that the net profit in 2021 will be about 21.6449 million yuan to 36.5247 million yuan, turning losses into profits compared with the previous year.
Xidi micro prospectus
Wednesday
Yidong Electronics:
The company is mainly engaged in the R & D, production and sales of precision electronic components such as FPC, connector components and LED backlight modules.
According to the prospectus, in 2013, based on the success of consumer electronics FPC, aiming at the application of FPC in new energy batteries and broad market space, the company began to develop power battery management system FPC, which was successfully mass produced in 2014, and became an important partner of Byd Company Limited(002594) and Contemporary Amperex Technology Co.Limited(300750) .
Yidong electronics expects the net profit to be RMB 200 million to RMB 225 million in 2021, an increase of 8.57% to 22.14% over the previous year.
Yidong electronic prospectus
Thursday
wanlang magnetoplastic:
The company is committed to the R & D, production, processing and sales of various refrigerator plastic parts with refrigerator door seal as the core, and the leading product is refrigerator door seal.
Wanlang magnetic plastic is expected to have a net profit of 130 million yuan to 150 million yuan in 2021, a decrease of 2.26% to an increase of 12.78% over the previous year.
Wanlang magnetoplastic prospectus
(source: Shanghai Securities News)
